Lapatinib 42291-0035
Product NDC
42291-0035- Manufacturer
- Avkare
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 12, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA217968
Need to source Lapatinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lapatinib Ditosylate | 250 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Packaging Options(1)
150 TABLET, FILM COATED in 1 BOTTLE (42291-035-15)